Virus therapy takes on bladder cancer: new hope for High-Risk patients?
NCT ID NCT07356791
First seen Jan 22, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study tests a new treatment for high-risk bladder cancer that hasn't spread into the muscle. The treatment uses a modified virus (adenovirus) that is put directly into the bladder through a catheter. The goal is to see if the virus can kill cancer cells and prevent the cancer from coming back. About 18 people will take part, and they will receive the treatment weekly for 6 weeks, then less often for up to 2 years. The study will check for side effects and how well the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.